Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1

Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1

US Patent 10781243 · Granted Sep 22, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD5 specific T cell receptor cell or gene therapy2025
CD22-specific T cell receptors and adoptive T cell therapy for treatment of B ce2025
High avidity antigen recognizing constructs2025
Roller embossing method for flexible graphite polar plates of fuel cells2025
Device for extracting polysaccharide from acaudina molpadioides2024
Flexible data security and machine learning system for merging third-party data2023
High avidity antigen recognizing constructs2022
Surgical tool tip and orientation determination2022
High avidity HPV T-cell receptors2022
Tool handedness determination for surgical videos2021
Dominant tool detection system for surgical videos2020
Liposome formulation for delivery of Wnt signal pathway inhibitor2020